[Effect of antimitotic chemotherapy of inoperable bronchopulmonary cancer on immune processes (tuberculin allergy, immune globulins)].
D000361:Agammaglobulinemia / Q000209:etiology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy / Q000276:immunology*; D004586:Electrophoresis; D006801:Humans; D007122:Immunoelectrophoresis; D008175:Lung Neoplasms / Q000188:drug therapy / Q000276:immunology*; D014374:Tuberculin Test; D005719:gamma-Globulins
D000970:Antineoplastic Agents; D005719:gamma-Globulins
Incidence de la chimiothérapie antimitotique des cancers broncho-pulmonaires inopérables sur les processus immunitaires (allergie tuberculinique, globulines immunitaires)